2023 Meeting Accreditation

For accreditation information and to view all speaker and moderator disclosures, please view the 2023 CME Packet. 


Earn CME credit by completeing the pre-test and post-test surveys:

Post-test for Enduring Content:


Post-test for CSL Behring Symposium:


Post-test for Veloxis Symposium:



Cutting Edge of Transplantation 

February 23-25, 2023

Target Audience

The educational design of this activity addresses the needs of healthcare professionals (physicians, surgeons, pharmacists, nurses, and others) and researchers working in the field of transplantation.

Educational Objectives

The following overarching objectives and more specific goals have been identified for this meeting. Having participated in this meeting, attendees will be able to:

  • Define the access challenge in organ transplantation.
  • Recognize the current barriers at each step in the transplant process for patients requiring transplant care.
  • Identify innovative strategies to mitigate disparities and expand patient access to transplant care.
  • Discuss recommended approaches to decrease disparities at one’s transplant center.

Statement of Need/Program Overview

For many people with end-stage organ failure, an organ transplant becomes their only effective treatment option and remains the gold standard for end stage organ disease. Access to organ transplantation is a complex and challenging process through which a patient needs to progress through multiple sequential steps from the diagnosis of end stage organ disease to organ transplantation. This multiple step process includes but is not limited to 1) timely recognition and mitigation of the chronic disease state by the practicing clinician, 2) timely referral to a transplant center when there is progression to end organ disease to realize the benefit of transplantation , 2) in person evaluation at a transplant center, 3) the need for laboratory and radiographic testing for medical clearance, 4) discussion and approval at transplant selection meetings, 6) insurance approval for transplant, 7) placement as an active candidate on the transplant waiting list, 8) follow up appointments and medical testing to remain active on the wait list, 9) having suitable access to available deceased donor organs, and 10) undergoing successful organ transplant. A recent report from the National Academy of Sciences Engineering and Medicine entitled 3 “Realizing the Promise of Equity in the Organ Transplantation System” identified barriers to equitable patient access in the current organ transplant system. The report made recommendations to address disparities in the current system and identify strategies for improvement. CEoT 2023 will focus on identifying the barriers that exist for patients on this complex journey to organ transplantation and more importantly focuses on providing innovative strategies and potential solutions to overcome these barriers in an effort to optimize access for all solid organ transplant candidates. We will examine each step in the process as defined above and these steps will serve as the backbone for discussion during each of the sessions during the meeting. Our sessions will also include active participation from transplant recipients both in show casing their own transplantation journey as well as panel discussants so that all in the audience can learn from experts in the field as well as the patient experience moving along the transplant process.

Continuing Education Credit

This activity is jointly provided by Global Education Group and American Society of Transplantation.



How to Claim Credit

Following the meeting, all participants will receive a link to an online evaluation form. After completing this evaluation, participants may claim a certificate noting the appropriate amount of credit or request a general certificate of attendance.

For pharmacist learners, partial credit may not be awarded, so sessions must be attended in their entirety to claim credit.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and American Society of Transplantation. Global is accredited by the ACCME to provide continuing medical education for physicians.

Global Education Group designates this live activity for 14.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Questions about Accreditation

For information about the accreditation of this program, please contact Global at 303-395-1782 or CME@globaleducationgroup.com.

Disclosure of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and American Society of Transplantation do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities